AR-R17779 je lek koji deluje kao potentan i selektivan pun agonist za α7 podtip neurskih nikotinskih acetilholinskih receptora.[5][6] On ispoljava nootropne efekte u životinjskim studijama,[7][8] mada ta dejstva ne zamenjuju dejstva nikotina.[9] On je nedavno izučavan kao potentan nov tretman za artritis.[10]
AR-R17779
|
|
IUPAC ime
|
|
(2S)-2′H-spiro[4-azabiciklo[2.2.2]oktan-2,5'-[1,3]oksazolidin]-2'-on |
|
Identifikacija
|
CAS registarski broj
|
178419-47-1 Y
|
PubChem[1][2]
|
5310971
|
ChemSpider[3]
|
4470515 Y
|
ChEBI
|
CHEBI:420311
|
ChEMBL[4]
|
CHEMBL193016 Y
|
Jmol-3D slike
|
Slika 1
|
|
O=C3O[C@]1(CN2CCC1CC2)CN3 |
|
|
InChI=1S/C9H14N2O2/c12-8-10-5-9(13-8)6-11-3-1-7(9)2-4-11/h7H,1-6H2,(H,10,12)/t9-/m0/s1 Y Kod: TYAGAVRSOFABFO-VIFPVBQEBZ Y
InChI=1/C9H14N2O2/c12-8-10-5-9(13-8)6-11-3-1-7(9)2-4-11/h7H,1-6H2,(H,10,12)/t9-/m0/s1 |
|
Svojstva
|
Molekulska formula
|
C9H14N2O2
|
Molarna masa
|
182.22 g mol−1
|
Y (šta je ovo?)
(verifikuj)
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje (25 °C, 100 kPa) materijala
|
Infobox references
|
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
- ↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
- ↑ Mullen, G.; Napier, A.; Balestra, M.; Decory, T.; Hale, G.; Macor, J.; Mack, R.; Loch J, J. i dr.. (2000). „(-)-Spiro1-azabicyclo2.2.2octane-3,5'-oxazolidin-2'-one, a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor”. Journal of Medicinal Chemistry 43 (22): 4045–4050. DOI:10.1021/jm000249r. PMID 11063601.
- ↑ Macor, J. .; Mullen, G. .; Verhoest, P. .; Sampognaro, A. .; Shepardson, B. .; Mack, R. . (2004). „A chiral synthesis of (-)-spiro1-azabicyclo2.2.2octane-3,5'- oxazolidin-2'-one: a conformationally restricted analogue of acetylcholine that is a potent and selective alpha7 nicotinic receptor agonist”. The Journal of Organic Chemistry 69 (19): 6493–6495. DOI:10.1021/jo049404q. PMID 15357617.
- ↑ Levin, E. D.; Bettegowda, C.; Blosser, J.; Gordon, J. (1999). „AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats”. Behavioural Pharmacology 10 (6–7): 675–680. DOI:10.1097/00008877-199911000-00014. PMID 10780509.
- ↑ Van Kampen, M.; Selbach, K.; Schneider, R.; Schiegel, E.; Boess, F.; Schreiber, R. (2004). „AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors”. Psychopharmacology 172 (4): 375–383. DOI:10.1007/s00213-003-1668-7. PMID 14727003.
- ↑ Grottick, A. J.; Trube, G.; Corrigall, W. A.; Huwyler, J.; Malherbe, P.; Wyler, R.; Higgins, G. A. (2000). „Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine”. The Journal of Pharmacology and Experimental Therapeutics 294 (3): 1112–1119. PMID 10945867.
- ↑ Van Maanen, M.; Lebre, M.; Van Der Poll, T.; Larosa, G.; Elbaum, D.; Vervoordeldonk, M.; Tak, P. (2009). „Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice”. Arthritis and rheumatism 60 (1): 114–122. DOI:10.1002/art.24177. PMID 19116908.
Spoljašnje veze
uredi